Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin
about
sameAs
A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activityTherapeutic effects of nitric oxide-aspirin hybrid drugsMechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsDesign and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.Recent developments in nitric oxide donor drugs.Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) miceProdrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach.Pharmacological evaluation and preliminary pharmacokinetics studies of a new diclofenac prodrug without gastric ulceration effect.A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.A new furoxan NO-donor rabeprazole derivative and related compounds.Prodrugs of NSAIDs: A Review.
P2860
Q28200568-9398A449-D485-466C-B44A-1ED477E2BFFEQ28210282-9417834B-8513-4A5F-B33D-81C14F653B8FQ28218042-F9FD8CCE-16BF-4085-AF5D-C4E46324EC49Q35270733-D4FC24FC-80E2-46D2-B467-CBC0B15726A6Q36052815-40FAE875-9BB4-48F1-8D2D-38804873FD8CQ36124990-8C300EBF-73EC-452C-B619-F4050F7DB1A2Q36196462-F76D2738-8692-498E-A9B7-834A802185D4Q36282723-DBF8C4B2-E652-4523-91E4-1967AF15AA3AQ38068081-50C4DAD3-44BB-4EC2-ACB1-797D2F5A9F7BQ38260626-C58C283F-E7B9-41FB-A2CC-731448C63B08Q38558587-333F5646-D0DD-4B0D-8D20-B7B9B918F34EQ38976707-5364CB64-5591-4270-BCB7-9A8431FEA673Q42222966-29616468-2103-4B80-B33C-B0296B28D349Q42417725-337B6CA5-2E65-4EFD-8DCD-FB34BE38921DQ44578589-6DD70F55-F422-42F1-86BD-D65E980979E9Q49286550-52B74D9B-A6D2-4285-9BB5-FBF79343B8A7
P2860
Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@ast
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@en
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@nl
type
label
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@ast
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@en
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@nl
prefLabel
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@ast
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@en
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@nl
P2093
P50
P356
P1476
Antiinflammatory, gastrosparin ...... new NO-donor esters of aspirin
@en
P2093
Alberto Gasco
Clara Cena
Elena Guaita
Gabriella Coruzzi
Giuseppina Morini
Stuart P McElroy
P304
P356
10.1021/JM020969T
P407
P577
2003-02-27T00:00:00Z